> For the complete documentation index, see [llms.txt](https://docs.labatlas.com/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://docs.labatlas.com/using-lab-atlas/frequently-asked-questions.md).

# Frequently Asked Questions (FAQ)

## How should I define projects and when should I add new ones?

Projects represent the highest-level unit of work in Lab Atlas and are used for grouping child studies and assays. How you choose to define them is really up to your organization and its needs — think of a project as a long-running effort that may or may not have an expected end date. A few examples we have seen:

* Target Identification
* Disease areas (eg. cancer or liver disease)
* General platform or functional groups (eg. lab operations or platform development)
* Drug discovery, preclinical, and clinical programs

There is no need to plan or expect all related studies over the lifetime of an organization to fall under a single project. In the above example, it is likely that what eventually becomes a clinical-stage effort might start in Platform Development or Target ID before graduating to a preclinical project of its own. Study relationships and collections can be used to maintain links between studies grouped into different projects.

With this in mind, you should think about adding new projects whenever you feel like an effort has outgrown the existing ones, or whenever it feels like you are bundling too many unrelated studies into the same project.

## How should I define studies and when should I add new ones?

Study records in Lab Atlas are vaguely defined on purpose, allowing you to define a study in a number of different ways. A study can be a short-term sequencing experiment completed in a day-or-two, or it can be a long-running animal study that has many steps and may take multiple months. The one guiding principal for defining studies should be that they have a defined plan and definite end date. The study proposal, protocol, and results should be captured in your organization's electronic laboratory notebook, but a summary should be provided in the study description in Lab Atlas. If additional work needs to be done for a study that has already been completed, it is probably better to create a new study and link it to the existing one, rather than add additional assays to a study that has already been marked complete (though Lab Atlas will not prevent you from doing this).